Seres Therapeutics, Inc.
NASDAQ:MCRB
0.8074 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 127.965 | 163.03 | 180.002 | 116.049 | 65.126 | 85.82 | 36.088 | 54.539 | 73.933 | 114.185 | 1.654 | 6.215 |
| Short Term Investments
| 0 | 18.311 | 110.704 | 137.567 | 29.69 | 0 | 113.895 | 138.704 | 131.149 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 127.965 | 181.341 | 290.706 | 253.616 | 94.816 | 85.82 | 149.983 | 193.243 | 205.082 | 114.185 | 1.654 | 6.215 |
| Net Receivables
| 8.674 | 0 | 0 | 9.387 | 1.785 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 29.647 | 0 | 0 | 0 | -29.69 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 9.124 | 13.423 | 12.922 | 5.774 | 33.278 | 6.845 | 5.095 | 5.126 | 2.528 | 0.058 | 0.051 | 0.03 |
| Total Current Assets
| 175.41 | 194.764 | 303.628 | 268.777 | 100.189 | 92.665 | 155.078 | 198.369 | 207.61 | 114.243 | 1.705 | 6.245 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 132.25 | 133.969 | 36.146 | 22.938 | 30.851 | 26.294 | 32.931 | 36.125 | 7.751 | 1.264 | 0.352 | 0.266 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 9.586 | 9.586 | 0.495 | 49.825 | 1.4 | 1.4 | 1.513 | 36.752 | 1.539 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 41.354 | 10.465 | 14.59 | 1.4 | 0 | 0.113 | 0 | 1.4 | 0 | 1.838 | 0.068 | -0.266 |
| Total Non-Current Assets
| 183.19 | 154.02 | 51.231 | 74.163 | 32.251 | 27.807 | 34.444 | 74.277 | 9.29 | 3.102 | 0.42 | 0.266 |
| Total Assets
| 358.6 | 348.784 | 354.859 | 342.94 | 132.44 | 120.472 | 189.522 | 272.646 | 216.9 | 117.345 | 2.125 | 6.538 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 3.641 | 17.44 | 13.735 | 4.018 | 4.859 | 6.415 | 7.033 | 7.587 | 5.397 | 2.166 | 0.393 | 0.112 |
| Short Term Debt
| 6.677 | 4.057 | 6.61 | 5.569 | 4.456 | 12.066 | 9.216 | 7.496 | 0 | 1.2 | 0.4 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 7.73 | 4.259 | 16.819 | 22.602 | 25.794 | 20.419 | 12.079 | 12.058 | 0 | 1.459 | 0.248 | 0 |
| Other Current Liabilities
| 80.611 | 59.84 | 45.094 | 14.226 | 10.884 | 3.141 | 3.297 | 3.316 | 5.523 | 0.278 | 0.015 | 0.066 |
| Total Current Liabilities
| 98.659 | 85.596 | 82.258 | 46.415 | 45.993 | 42.041 | 31.625 | 30.457 | 10.92 | 5.103 | 1.056 | 0.178 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 101.544 | 158.533 | 42.601 | 35.2 | 40.324 | 7.25 | 8.989 | 10.73 | 0 | 1.304 | 0.438 | 0 |
| Deferred Revenue Non-Current
| 95.364 | 92.43 | 86.998 | 85.572 | 93.945 | 116.84 | 84.847 | 96.756 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 105.715 | 0 | 0 | 0 | 0 | -5.034 | -6.756 | -10.73 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 2.174 | 1.442 | 11.495 | 1.003 | 0.502 | 7.42 | 10.118 | 12.802 | 0.586 | 137.659 | 11.747 | 0 |
| Total Non-Current Liabilities
| 304.797 | 252.405 | 141.094 | 121.775 | 134.771 | 126.476 | 97.198 | 109.558 | 0.586 | 138.963 | 12.185 | 0 |
| Total Liabilities
| 403.456 | 338.001 | 223.352 | 168.19 | 180.764 | 168.517 | 128.823 | 140.015 | 11.506 | 144.066 | 13.241 | 0.178 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 189.522 | 272.646 | 216.9 | 137.659 | 11.747 | 10.708 |
| Common Stock
| 0.135 | 0.125 | 0.092 | 0.091 | 0.07 | 0.041 | 0.04 | 0.04 | 0.039 | 0.007 | 0.007 | 0.007 |
| Retained Earnings
| -978.235 | -864.511 | -614.354 | -548.776 | -459.649 | -389.37 | -263.571 | -174.191 | -82.612 | -27.832 | -11.123 | -4.355 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0.012 | -0.06 | -0.047 | 0 | -20.301 | -0.146 | -0.149 | 0.03 | -137.659 | 0 | 0 |
| Other Total Stockholders Equity
| 933.244 | 875.181 | 745.829 | 723.482 | 411.255 | 361.585 | 134.854 | 34.285 | 71.037 | 1.104 | -11.747 | 0 |
| Total Shareholders Equity
| -44.856 | 10.783 | 131.507 | 174.75 | -48.324 | -48.045 | 60.699 | 132.631 | 205.394 | -26.721 | -11.116 | 6.36 |
| Total Equity
| -44.856 | 10.783 | 131.507 | 174.75 | -48.324 | -48.045 | 60.699 | 132.631 | 205.394 | -26.721 | -11.116 | 6.36 |
| Total Liabilities & Shareholders Equity
| 358.6 | 348.784 | 354.859 | 342.94 | 132.44 | 120.472 | 189.522 | 272.646 | 216.9 | 117.345 | 2.125 | 0 |